Abstract
Practice PearlIn patients requiring chronic nonsteroidal antiinflammatory drug therapy, PN 400 (enteric-coated naproxen with esomeprazole) effectively reduces the risk of developing gastric and duodenal ulcers compared with enteric-coated naproxen alone.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
